The onus is now on the drug companies that own patents on key AIDS medicines to put their patents in the Pool. If companies are genuine about wanting to boost access to newer medicines, then they must license the patents that are actually blocking generic production and will make a real difference to people’s lives.
Tracks
18 notes
via Doctors Without Borders-
speak-life reblogged this from doctorswithoutborders
-
emilymlarson reblogged this from doctorswithoutborders
-
aymanfadel reblogged this from doctorswithoutborders
-
aymanfadel likes this
-
silas216 reblogged this from doctorswithoutborders
-
silas216 likes this
-
adonna likes this
-
wetjewels reblogged this from doctorswithoutborders
-
ouiii reblogged this from doctorswithoutborders
-
gustadora likes this
-
w3fa likes this
-
berezina likes this
-
ninjatengu reblogged this from doctorswithoutborders
-
ninjatengu likes this
-
hisbestmemories likes this
-
speak-life likes this
-
doctorswithoutborders posted this
